366 Ringraziamenti Si ringraziano tutti i componenti dei Centri Trapianto afferenti alla Rete Trapianto Metropolitana - Rome Transplant Network per il prezioso contributo. Bibliografia [1] Hirsch HH, Pergam SA. Human adenovirus, polyomavirus, and parvovirus infections in patients undergoing hematopoietic stem-cell transplantation. In: Forman SJ, Nagrin RS, Antin H, Appelbaum FR, editors. Thomas’ hematopoietic cell transplantation. 5th ed. Hoboken: Wiley; 2016. p. 1090–104 [2] Lunde LE, Dasaraju S, Cao Q, et al. Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival. Bone Marrow Transplant 2015; 50: 1432–1437 [3] Ngo D, Samuels D,Chen J,Koller BP, Al Malki M. A Clinical Review of the Different Strategies to Minimize Hemorrhagic Cystitis Associated with the Use of Post-Transplantation Cyclophosphamide in an Allogeneic Transplant. 2022; In press [4] Blackard JT, Davies SM and Laskin BL. BK polyomavirus diversity – why viral variation matters. Rev Med Virol 2020; 30: e2102 [5] Cesaro S, Dalianis T, Hanssen Rinaldo C, et al. ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients. J Antimicrob Chemother. 2018; 73:12–21. [6] Laskin BL, Denburg MR, Furth SL, et al. The natural history of BK polyomavirus and the host immune response after stem cell transplantation. Clin Infect Dis. Epub ahead of print 18 December 2019. DOI: 10.1093/cid/ciz1194 [7] Leung AY, Yuen KY and Kwong YL. Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm. Bone Marrow Transplant 2005; 36: 929–937 [8] Cesaro S, Tridello G, Pillon M, et al. A prospective study on the predictive value of plasma BK virus-DNA load for hemorrhagic cystitis in pediatric patients after stem cell transplantation. J Pediatric Infect Dis Soc. 2015; 4:134–42. [9] Kanakry CG, Coffey DG, Towlerton AM, et al. Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide. JCI Insight 2016; 1: e86252. [10] Comoli P, Hirsch HH and Ginevri F. Cellular immune responses to BK virus. Curr Opin Organ Transplant 2008; 13: 569–574 [11] Ambalathingal GR, Francis RS, Smyth MJ, et al. BK polyomavirus: clinical aspects, immune regulation, and emerging therapies. Clin Microbiol Rev 2017; 30: 503–528 [12] Bedi A, Miller CB, Hanson JL, et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995; 13: 1103–1109 [13] Bogdanovic G, Priftakis P, Giraud G, et al. Association between a high BK virus load in urine samples of patients with graftversus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation. J Clin Microbiol 2004; 42: 5394–5396 [14] Leung AY, Suen CK, Lie AK, et al. Quantification of polyoma BK viruria in.hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001; 98: 1971–1978. [15] Erard V, Kim HW, Corey L, et al. BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood. 2005;106:1130–1132 [16] Coomes EA, Wolfe Jacques A, Michelis FV, et al. Efficacy of cidofovir in treatment of BK virus-induced hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 2018; 24: 1901–1905 [17] Mackey MC. Intravesicular cidofovir for the treatment of polyomavirus-associated hemorrhagic cystitis. Ann Pharmacother 2012; 46: 442–446. [18] Cesaro S, Hirsch HH, Faraci M, et al. Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study. Clin Infect Dis. 2009;49:233–40 [19] Ghosh A, Tan TT, Linn YC, et al. What we learned from plasma BK-virus monitoring in allogeneic hematopoietic transplant recipients. Transplantation 2016; 100: e17–e18. [20] Imlay H, Xie H, Leisenring WM, et al. Presentation of BK polyomavirus-associated hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. Blood Adv 2020; 4: 617–628. [21] Visintini C, Venturini M, Botti S, et al. Nursing management of haemorrhagic cystitis in patients undergoing haematopoietic stem cell transplantation: a multicentre Italian survey. Mediterr J Hematol Infect Dis 2019; 11: e2019051 [22] Cheuk DK, Lee TL, Chiang AK, et al. Risk factors and treatment of hemorrhagic cystitis in children who underwent hematopoietic stem cell transplantation. Transpl Int 2007; 20: 73–81. [23] Ganguly N, Clough LA, Dubois LK, et al. Low-dose cidofovir in the treatment of symptomatic BK virus infection in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis of an algorithmic approach. Transpl Infect Dis. 2010;12:406–11 [24] Bridges B, Donegan S, Badros A. Cidofovir bladder instillation for the treatment of BK hemorrhagic cystitis after allogeneic stem cell transplantation. Am J Hematol. 2006;81:535–7. [25] Zama D, Masetti R, Vendemini F, et al. Clinical effectiveness of early treatment with hyperbaric oxygen therapy for severe late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in pediatric patients. Pediatr Transplant. 2013;17:86–91. [26] Tirindelli MC, Flammia GP, Bove P, et al. Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014;20:1612– 7.6 Tirindelli et al.: La Cistite Emorragica 27] Masieri L, Sessa F, Mari A, et al. Intravesical application of platelet-rich plasma in patients with persistent haemorrhagic cystitis after hematopoietic stem cell transplantation: a single centre preliminary experience. Int Urol Nephrol 2019; 51: 1715–1720. [28] Ringden O, Uzunel M, Sundberg B, et al. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia. 2007;21:2271–6. [29] Tzannou I, Papadopoulou A, Naik S, et al. Off-the-shelf virus specific T cells to treat BK virus, human herpes virus 6, cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem cell transplantation. J Clin Oncol. 2017;35:3547–57 [30] Najafabadi MM, Soleimani M,Ahmadvand M , Zomorrod MS , Asadollah Mousavi S. Treatment protocols for BK virus associated hemorrhagic cystitis after hematopoietic stem cell transplantation. Am J Blood Res 2020;10(5):217-230 [31] Aditya J, Kundan M , Rajeev S, Kamal Kant S. Management of BK virus-associated haemorrhagic cystitis in allogeneic stem cell transplant recipients. Ther Adv Infectious Dis 2021, Vol. 8: 1–13
RkJQdWJsaXNoZXIy ODUzNzk5